Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis (2010)
Source: New England Journal of Medicine. Unidade: FMRP
Subjects: DOENÇAS DO SISTEMA NERVOSO, FÁRMACOS IMUNOSSUPRESSORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COHEN, Jeffrey A. et al. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. New England Journal of Medicine, v. 362, n. 5, p. 402-415, 2010Tradução . . Acesso em: 19 nov. 2024.APA
Cohen, J. A., Barkhof, F., Comi, G., Hartung, H. -P., Khatri, B. O., Montalban, X., et al. (2010). Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. New England Journal of Medicine, 362( 5), 402-415.NLM
Cohen JA, Barkhof F, Comi G, Hartung H-P, Khatri BO, Montalban X, Pelletier J, Capra R, Gallo P, Izquierdo G, Tiel-Wilck K, Vera A de, Jin J, Stites T, Wu S, Aradhye S, Kappos L, Barreira AA. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. New England Journal of Medicine. 2010 ; 362( 5): 402-415.[citado 2024 nov. 19 ]Vancouver
Cohen JA, Barkhof F, Comi G, Hartung H-P, Khatri BO, Montalban X, Pelletier J, Capra R, Gallo P, Izquierdo G, Tiel-Wilck K, Vera A de, Jin J, Stites T, Wu S, Aradhye S, Kappos L, Barreira AA. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. New England Journal of Medicine. 2010 ; 362( 5): 402-415.[citado 2024 nov. 19 ]
